Filter News
Area of Research
- (-) Nuclear Science and Technology (12)
- Advanced Manufacturing (22)
- Biological Systems (1)
- Biology and Environment (69)
- Biology and Soft Matter (1)
- Building Technologies (1)
- Clean Energy (142)
- Climate and Environmental Systems (2)
- Computational Biology (2)
- Computational Engineering (2)
- Computer Science (3)
- Electricity and Smart Grid (3)
- Functional Materials for Energy (1)
- Fusion and Fission (7)
- Fusion Energy (1)
- Isotopes (25)
- Materials (74)
- Materials for Computing (6)
- Mathematics (1)
- National Security (31)
- Neutron Science (27)
- Quantum information Science (2)
- Sensors and Controls (1)
- Supercomputing (56)
News Topics
- (-) 3-D Printing/Advanced Manufacturing (4)
- (-) Biomedical (2)
- (-) Cybersecurity (1)
- (-) Isotopes (5)
- (-) Physics (2)
- Advanced Reactors (11)
- Bioenergy (1)
- Computer Science (2)
- Coronavirus (1)
- Decarbonization (1)
- Environment (1)
- Fusion (8)
- Materials Science (3)
- Molten Salt (4)
- Neutron Science (5)
- Nuclear Energy (36)
- Space Exploration (5)
- Sustainable Energy (1)
- Transformational Challenge Reactor (3)
Media Contacts
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.
After more than a year of operation at the Department of Energy’s (DOE’s) Oak Ridge National Laboratory (ORNL), the COHERENT experiment, using the world’s smallest neutrino detector, has found a big fingerprint of the elusive, electrically neutral particles that interact only weakly with matter.